Cargando…

Effects of the anti-diabetic imeglimin in hyperglycemic mice with septic shock

Detalles Bibliográficos
Autores principales:	Wagner, F, Vogt, J, Wachter, U, Weber, S, Stahl, B, Groeger, M, McCook, O, Georgieff, M, Fouqueray, P, Kuhn, T, Calzia, E, Radermacher, P, Fontaine, E, Wagner, K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363439/ http://dx.doi.org/10.1186/cc10628

Ejemplares similares

Adrenomedullin blockade improves catecholamine responsiveness and kidney function in resuscitated murine septic shock
por: Wagner, K, et al.
Publicado: (2012)

Adrenomedullin binding improves catecholamine responsiveness and kidney function in resuscitated murine septic shock
por: Wagner, Katja, et al.
Publicado: (2013)

Effects of temperature and H(2)S inhalation on glucose metabolism in murine resuscitated septic shock
por: Baumgart, K, et al.
Publicado: (2010)

Effects of glycemic control on glucose utilization and mitochondrial respiration during resuscitated murine septic shock
por: Vogt, Josef A, et al.
Publicado: (2014)

Impact of hyperglycemia on cystathionine-γ-lyase expression during resuscitated murine septic shock
por: Merz, Tamara, et al.
Publicado: (2017)

Time-dependent effects of intravenous H(2)S during long-term, resuscitated porcine hemorrhagic shock
por: Bracht, H, et al.
Publicado: (2010)

Effects of the PPAR-β/δ agonist GW0742 during resuscitated porcine septic shock
por: Wepler, Martin, et al.
Publicado: (2013)

Reduced expression of PPAR-β/δ limits the potential beneficial effects of GW0742 during septic shock in atherosclerotic swine
por: Bracht, H, et al.
Publicado: (2012)

Effect of intravenous H(2)S on porcine aortic occlusion-induced systemic inflammation and kidney ischemia/reperfusion injury
por: Wagner, F, et al.
Publicado: (2010)

Is β-adrenergic receptor stimulation crucial for splanchnic O(2) availability in septic shock?
por: Reinelt, H, et al.
Publicado: (1997)

Comparison of carbamylated versus recombinant erythropoietin during spinal cord ischemia/reperfusion injury
por: Simon, F, et al.
Publicado: (2010)

Epinephrine kinetics in septic shock – a means to understand variable catecholamine efficiency?
por: Calzia, Enrico, et al.
Publicado: (2009)

Left ventricular function during porcine-resuscitated septic shock with pre-existing atherosclerosis
por: Nußbaum, Benedikt L., et al.
Publicado: (2016)

Erratum to: Left ventricular function during porcine-resuscitated septic shock with pre-existing atherosclerosis
por: Nußbaum, Benedikt L., et al.
Publicado: (2016)

Pharmacokinetics of Imeglimin in Caucasian and Japanese Healthy Subjects
por: Fouqueray, Pascale, et al.
Publicado: (2022)

Reduced lactic acidosis risk with Imeglimin: Comparison with Metformin
por: Theurey, Pierre, et al.
Publicado: (2022)

Pre-emptive hypothermia during resuscitated porcine hemorrhagic shock
por: Matallo, J, et al.
Publicado: (2012)

Year in review 2007: Critical Care – shock
por: Wagner, Florian, et al.
Publicado: (2008)

Mechanism of action of Imeglimin: A novel therapeutic agent for type 2 diabetes
por: Hallakou‐Bozec, Sophie, et al.
Publicado: (2020)

Improved hepatic glucose production in mice lacking inducible nitric oxide synthase during hyperdynamic septic shock
por: Barth, E, et al.
Publicado: (2006)

To the Editor:
por: Radermacher, Peter, et al.
Publicado: (2021)

Imeglimin prevents human endothelial cell death by inhibiting mitochondrial permeability transition without inhibiting mitochondrial respiration
por: Detaille, D, et al.
Publicado: (2016)

Mitochondrial respiration and cytochrome c inhibition by sulfide in peritoneal macrophages in vitro: effects of temperature and pH
por: Groeger, M, et al.
Publicado: (2010)

Parallel determination of glucose metabolism and fractional synthesis rates of individual hepatic proteins during hyperdynamic septic shock
por: Vogt, J, et al.
Publicado: (2006)

Reduced EPO receptor expression may contribute to limited pleiotropic effects of EPO during critical illness
por: McCook, O, et al.
Publicado: (2012)

Does O(2) availability determine hepatic metabolic activity in septic shock?
por: Reinelt, H, et al.
Publicado: (1997)

Influence of iloprost on hepato splanchnic metabolic activity and energy balance in patients with septic shock
por: Kiefer, P, et al.
Publicado: (2000)

Coagulation profile in hyperglycemic septic shock patients
por: Sanches, LC, et al.
Publicado: (2010)

Sepsis therapy: what's the best for the mitochondria?
por: Wagner, Florian, et al.
Publicado: (2008)

Glucose metabolism during hyperdynamic septic shock: comparison between noradrenaline and vasopressin
por: Hauser, B, et al.
Publicado: (2008)

Respiratory mechanics during nitrous oxide and xenon anesthesia with and without metacholine-induced bronchoconstriction
por: Calzia, E, et al.
Publicado: (1998)

Arterial oxygen partial pressures during nitrous oxide and xenon elimination
por: Stahl, W, et al.
Publicado: (1998)

Vasopressin in vasodilatory shock: is the heart in danger?
por: Hauser, Balázs, et al.
Publicado: (2008)

Effect of dopexamine on CO(2) -gradients and splanchnic energy balance in septic shock
por: Kiefer, P, et al.
Publicado: (1999)

Imeglimin amplifies glucose-stimulated insulin release from diabetic islets via a distinct mechanism of action
por: Hallakou-Bozec, Sophie, et al.
Publicado: (2021)

Blunt Chest Trauma in Mice after Cigarette Smoke-Exposure: Effects of Mechanical Ventilation with 100 % O(2)
por: Wagner, Katja, et al.
Publicado: (2015)

The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy
por: Fouqueray, Pascale, et al.
Publicado: (2013)

Effect of a dopexamine induced increase in cardiac output on splanchnic hemodynamics in septic shock
por: Kiefer, P, et al.
Publicado: (1999)

Effects of Sodium Thiosulfate During Resuscitation From Trauma-and-Hemorrhage in Cystathionine-γ-Lyase Knockout Mice With Diabetes Type 1
por: Gröger, Michael, et al.
Publicado: (2022)

Phase 2 trial with imeglimin in patients with Type 2 diabetes indicates effects on insulin secretion and sensitivity
por: Theurey, Pierre, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9a2m7hm1nu7eddediu1docmcsh